Kedrion Biopharma Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 5,200

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Financing Rounds
  • 14

  • Investments
  • 7

Kedrion Biopharma General Information

Description

Manufacturer of plasma-derived products intended for the treatment of patients suffering from rare and chronic conditions. The company develops, produces and distributes human plasma-derived therapies for use in the treatment of hemophilia, immunodeficiencies and other severe debilitating conditions, enabling clients to get safer products.

Contact Information

Website
www.kedrion.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Loc. Ai Conti
  • Castelvecchio Pascoli
  • 55051 Barga(Lucca)
  • Italy
+39 0583
Primary Industry
Biotechnology
Other Industries
BPO/Outsource Services
Therapeutic Devices
Corporate Office
  • Loc. Ai Conti
  • Castelvecchio Pascoli
  • 55051 Barga(Lucca)
  • Italy
+39 0583

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kedrion Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kedrion Biopharma‘s full profile, request access.

Request a free trial

Kedrion Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of plasma-derived products intended for the treatment of patients suffering from rare and chronic condition
Biotechnology
Barga, Italy
5,200 As of 2025

Mobile, AL
 

King Of Prussia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kedrion Biopharma Competitors (4)

One of Kedrion Biopharma’s 4 competitors is KEDPlasma, a Corporation company based in Mobile, AL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
KEDPlasma Corporation Mobile, AL
CSL Behring Corporation King Of Prussia, PA
Assertio Holdings Formerly VC-backed Lake Forest, IL
Regenxbio Formerly VC-backed Rockville, MD
To view Kedrion Biopharma’s complete competitors history, request access »

Kedrion Biopharma Patents

Kedrion Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017326469-A1 Process for plasminogen purification starting from human plasma Inactive 13-Sep-2016
CA-3036425-A1 Process for plasminogen purification starting from human plasma Pending 13-Sep-2016
EP-3512940-A1 Process for plasminogen purification starting from human plasma Active 13-Sep-2016
US-11591587-B2 Process for plasminogen purification starting from human plasma Active 13-Sep-2016
US-20190330611-A1 Process for plasminogen purification starting from human plasma Active 13-Sep-2016 C12N9/6435
To view Kedrion Biopharma’s complete patent history, request access »

Kedrion Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kedrion Biopharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kedrion Biopharma‘s full profile, request access.

Request a free trial

Kedrion Biopharma Investments (7)

Kedrion Biopharma’s most recent deal was a Buyout/LBO with UNICAplasma. The deal was made on 05-Dec-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
UNICAplasma 05-Dec-2022 Buyout/LBO Clinics/Outpatient Services
Bio Products Laboratory 01-Sep-2022 Buyout/LBO Biotechnology
Grifols Canada Plasma 21-May-2021 Buyout/LBO Other Pharmaceuticals and Biotechnology
Entegrion 19-Mar-2014 Later Stage VC Diagnostic Equipment
Ortho Clinical Diagnostics (RhoGam Business) 31-Jul-2012 Buyout/LBO Clinics/Outpatient Services
You’re viewing 5 of 7 investments. Get the full list »

Kedrion Biopharma Exits (1)

Kedrion Biopharma’s most recent exit was on 21-May-2021 from Grifols Canada Plasma. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Grifols Canada Plasma 21-May-2021 Completed
  • 3 buyers
To view Kedrion Biopharma’s complete exits history, request access »

Kedrion Biopharma Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Bio Products Laboratory Elstree, United Kingdom 1952
UNICAplasma Prague, Czech Republic

Kedrion Biopharma FAQs

  • When was Kedrion Biopharma founded?

    Kedrion Biopharma was founded in 2001.

  • Where is Kedrion Biopharma headquartered?

    Kedrion Biopharma is headquartered in Barga, Italy.

  • What is the size of Kedrion Biopharma?

    Kedrion Biopharma has 5,200 total employees.

  • What industry is Kedrion Biopharma in?

    Kedrion Biopharma’s primary industry is Biotechnology.

  • Is Kedrion Biopharma a private or public company?

    Kedrion Biopharma is a Private company.

  • What is Kedrion Biopharma’s current revenue?

    The current revenue for Kedrion Biopharma is .

  • How much funding has Kedrion Biopharma raised over time?

    Kedrion Biopharma has raised $1.78B.

  • Who are Kedrion Biopharma’s investors?

    Abu Dhabi Investment Authority, Ampersand (Massachusetts), FSI (Italy), Permira, and CDP Equity are 5 of 7 investors who have invested in Kedrion Biopharma.

  • Who are Kedrion Biopharma’s competitors?

    KEDPlasma, CSL Behring, Assertio Holdings, and Regenxbio are competitors of Kedrion Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »